Nifty

:

16352.45

Sensex

:

54884.66

182.30 (1.13%)
632.13 (1.17%)

Login

Nifty
Sensex

:
:

16352.45
54884.66

182.30 (1.13%)
632.13 (1.17%)

Ipca Laboratories Ltd.

Pharmaceuticals & Drugs - Global

Rating :

53/99

BSE: 524494 | NSE: IPCALAB

Watchlist

NSE BSE

916.25

26-May-2022

Open
High
Low
Previous Close

937.90
939.00
908.40
937.90

Volume
Traded Value (lacs)
52 Week High
52 Week Low

1271410
11676.57
1383.10
908.40

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

23,268.48
26.40
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

23,155.75
0.44%
4.25

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

8.64
11.32
12.93

EBITDA CAGR (%)

10 Years
5 Years
3 Years

13.23
28.95
16.91

PAT CAGR (%)

10 Years
5 Years
3 Years

15.31
41.43
36.89

P:E (Median)

8 Years
5 Years
3 Years

32.28
31.05
27.56

P:BV (Average)

8 Years
5 Years
3 Years

4.23
4.49
5.23

EV:EBITDA (Average)

8 Years
5 Years
3 Years

18.41
18.66
18.63

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 22 Mar 21 Var% Dec 21 Dec 20 Var% Sep 21 Sep 20 Var% Jun 21 Jun 20 Var%
Net Sales 1,168.45 1,040.92 12.25% 1,328.47 1,315.22 1.01% 1,423.84 1,297.77 9.71% 1,478.60 1,485.25 -0.45%
Expenses 989.43 824.28 20.04% 1,016.95 966.39 5.23% 1,064.82 937.61 13.57% 1,084.62 897.30 20.88%
EBITDA 179.02 216.64 -17.37% 311.52 348.83 -10.70% 359.02 360.16 -0.32% 393.98 587.95 -32.99%
EBIDTM 15.32% 20.81% 23.45% 26.52% 25.21% 27.75% 26.65% 39.59%
Other Income 14.21 19.91 -28.63% 13.24 15.65 -15.40% 15.07 15.00 0.47% 13.61 11.68 16.52%
Interest 3.21 2.31 38.96% 1.27 1.56 -18.59% 1.47 1.81 -18.78% 1.26 2.46 -48.78%
Depreciation 52.39 48.57 7.86% 51.25 47.66 7.53% 50.50 46.26 9.17% 49.96 45.23 10.46%
PBT 137.63 185.67 -25.87% 272.24 315.26 -13.65% 322.12 327.09 -1.52% 356.37 551.94 -35.43%
Tax 27.22 34.19 -20.39% 54.07 55.29 -2.21% 64.48 51.41 25.42% 71.65 98.30 -27.11%
PAT 110.41 151.48 -27.11% 218.17 259.97 -16.08% 257.64 275.68 -6.54% 284.72 453.64 -37.24%
PATM 9.45% 14.55% 16.42% 19.77% 18.09% 21.24% 19.26% 30.54%
EPS 4.35 5.97 -27.14% 8.60 10.25 -16.10% 10.16 10.87 -6.53% 11.22 17.88 -37.25%

Description Mar 22 Mar 21 Var% Dec 21 Dec 20 Var% Sep 21 Sep 20 Var% Jun 21 Jun 20 Var%
Net Sales 1,289.10 1,114.66 15.65% 1,430.47 1,409.83 1.46% 1,544.43 1,361.10 13.47% 1,565.79 1,534.40 2.05%
Expenses 1,069.77 885.75 20.78% 1,122.66 1,042.90 7.65% 1,178.85 1,000.91 17.78% 1,149.25 946.08 21.47%
EBITDA 219.33 228.91 -4.19% 307.81 366.93 -16.11% 365.58 360.19 1.50% 416.54 588.32 -29.20%
EBIDTM 17.01% 20.54% 21.52% 26.03% 23.67% 26.46% 26.60% 38.34%
Other Income 14.54 19.92 -27.01% 12.93 15.38 -15.93% 18.08 15.45 17.02% 21.02 12.09 73.86%
Interest 3.38 1.70 98.82% 1.43 2.29 -37.55% 1.06 2.31 -54.11% 1.82 2.74 -33.58%
Depreciation 60.94 52.50 16.08% 58.65 53.52 9.59% 56.96 52.12 9.29% 55.87 51.03 9.48%
PBT 169.55 194.63 -12.89% 260.66 326.50 -20.17% 325.64 321.21 1.38% 379.87 546.64 -30.51%
Tax 28.76 30.93 -7.02% 57.33 56.73 1.06% 67.91 52.59 29.13% 70.77 99.89 -29.15%
PAT 140.79 163.70 -14.00% 203.33 269.77 -24.63% 257.73 268.62 -4.05% 309.10 446.75 -30.81%
PATM 10.92% 14.69% 14.21% 19.13% 16.69% 19.74% 19.74% 29.12%
EPS 5.13 6.36 -19.34% 3.88 10.46 -62.91% 9.86 10.53 -6.36% 12.09 17.65 -31.50%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Net Sales 5,399.36 5,114.11 4,337.82 3,605.66 3,193.40 3,102.21 2,843.06 3,087.84 3,234.82 2,771.24 2,326.60 Net Sales Growth 5.06% 17.90% 20.31% 12.91% 2.94% 9.12% -7.93% -4.54% 16.73% 19.11% Cost Of Goods Sold 1,763.12 1,402.41 1,292.23 1,010.36 966.04 936.63 891.24 956.40 953.85 949.52 795.06 Gross Profit 3,636.24 3,711.70 3,045.59 2,595.30 2,227.36 2,165.58 1,951.82 2,131.44 2,280.97 1,821.72 1,531.54 GP Margin 67.35% 72.58% 70.21% 71.98% 69.75% 69.81% 68.65% 69.03% 70.51% 65.74% 65.83% Total Expenditure 4,155.82 3,663.90 3,439.48 2,926.87 2,766.48 2,703.54 2,585.54 2,582.48 2,528.38 2,236.09 1,899.28 Power & Fuel Cost - 201.48 196.82 175.25 159.89 148.93 140.03 133.39 125.94 103.36 82.94 % Of Sales - 3.94% 4.54% 4.86% 5.01% 4.80% 4.93% 4.32% 3.89% 3.73% 3.56% Employee Cost - 948.84 870.79 752.24 712.78 674.93 603.35 541.22 477.86 376.57 322.20 % Of Sales - 18.55% 20.07% 20.86% 22.32% 21.76% 21.22% 17.53% 14.77% 13.59% 13.85% Manufacturing Exp. - 501.49 449.83 363.05 359.41 400.11 380.86 437.27 412.77 328.81 273.66 % Of Sales - 9.81% 10.37% 10.07% 11.25% 12.90% 13.40% 14.16% 12.76% 11.87% 11.76% General & Admin Exp. - 223.46 233.95 261.02 262.26 237.93 277.90 239.23 245.82 196.76 169.91 % Of Sales - 4.37% 5.39% 7.24% 8.21% 7.67% 9.77% 7.75% 7.60% 7.10% 7.30% Selling & Distn. Exp. - 323.91 355.23 317.80 275.05 281.33 226.94 248.38 234.50 213.47 197.27 % Of Sales - 6.33% 8.19% 8.81% 8.61% 9.07% 7.98% 8.04% 7.25% 7.70% 8.48% Miscellaneous Exp. - 62.31 40.63 47.15 31.05 23.68 65.22 26.59 77.64 67.60 197.27 % Of Sales - 1.22% 0.94% 1.31% 0.97% 0.76% 2.29% 0.86% 2.40% 2.44% 2.50% EBITDA 1,243.54 1,450.21 898.34 678.79 426.92 398.67 257.52 505.36 706.44 535.15 427.32 EBITDA Margin 23.03% 28.36% 20.71% 18.83% 13.37% 12.85% 9.06% 16.37% 21.84% 19.31% 18.37% Other Income 56.13 128.60 84.16 71.57 57.70 56.52 46.27 58.65 51.14 44.23 49.16 Interest 7.21 11.13 18.84 21.09 27.46 25.99 31.11 29.11 27.60 34.01 42.23 Depreciation 204.10 187.72 178.69 171.88 174.36 171.00 161.23 177.17 100.89 84.00 65.31 PBT 1,088.36 1,379.96 784.97 557.39 282.80 258.20 111.45 357.73 629.09 461.37 368.94 Tax 217.42 239.19 132.51 102.48 49.69 69.91 18.93 101.62 151.72 129.98 88.77 Tax Rate 19.98% 17.33% 16.88% 18.39% 17.57% 27.08% 16.99% 28.41% 24.12% 28.17% 24.06% PAT 870.94 1,140.77 652.46 454.91 233.11 188.29 92.52 256.11 477.37 331.39 280.17 PAT before Minority Interest 870.94 1,140.77 652.46 454.91 233.11 188.29 92.52 256.11 477.37 331.39 280.17 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 16.13% 22.31% 15.04% 12.62% 7.30% 6.07% 3.25% 8.29% 14.76% 11.96% 12.04% PAT Growth -23.65% 74.84% 43.43% 95.15% 23.80% 103.51% -63.87% -46.35% 44.05% 18.28% EPS 34.33 44.97 25.72 17.93 9.19 7.42 3.65 10.09 18.82 13.06 11.04

Description TTM Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Net Sales 5,829.79 5,394.94 4,619.03 3,745.69 3,257.76 3,156.19 2,867.11 3,144.40 3,281.77 2,805.94 2,355.96 Net Sales Growth 7.56% 16.80% 23.32% 14.98% 3.22% 10.08% -8.82% -4.19% 16.96% 19.10% Cost Of Goods Sold 2,014.85 1,547.98 1,455.41 1,090.34 978.34 939.40 903.04 968.00 963.06 955.10 800.91 Gross Profit 3,814.94 3,846.96 3,163.62 2,655.35 2,279.42 2,216.79 1,964.07 2,176.40 2,318.71 1,850.84 1,555.05 GP Margin 65.44% 71.31% 68.49% 70.89% 69.97% 70.24% 68.50% 69.22% 70.65% 65.96% 66.00% Total Expenditure 4,520.53 3,913.71 3,728.56 3,067.42 2,815.78 2,740.77 2,593.42 2,630.33 2,569.79 2,268.34 1,928.47 Power & Fuel Cost - 207.10 201.22 176.50 161.92 151.00 141.67 135.94 127.91 104.79 83.78 % Of Sales - 3.84% 4.36% 4.71% 4.97% 4.78% 4.94% 4.32% 3.90% 3.73% 3.56% Employee Cost - 1,013.57 921.23 787.40 735.88 695.98 625.58 566.70 497.99 391.79 335.49 % Of Sales - 18.79% 19.94% 21.02% 22.59% 22.05% 21.82% 18.02% 15.17% 13.96% 14.24% Manufacturing Exp. - 524.21 471.80 374.26 366.92 404.52 387.75 439.11 415.69 331.73 275.82 % Of Sales - 9.72% 10.21% 9.99% 11.26% 12.82% 13.52% 13.96% 12.67% 11.82% 11.71% General & Admin Exp. - 242.22 249.90 271.85 268.52 246.68 245.42 246.73 255.40 205.02 178.12 % Of Sales - 4.49% 5.41% 7.26% 8.24% 7.82% 8.56% 7.85% 7.78% 7.31% 7.56% Selling & Distn. Exp. - 324.86 359.15 317.84 277.62 280.74 223.67 245.00 231.18 212.94 196.09 % Of Sales - 6.02% 7.78% 8.49% 8.52% 8.89% 7.80% 7.79% 7.04% 7.59% 8.32% Miscellaneous Exp. - 53.77 69.85 49.23 26.58 22.45 66.29 28.85 78.56 66.97 196.09 % Of Sales - 1.00% 1.51% 1.31% 0.82% 0.71% 2.31% 0.92% 2.39% 2.39% 2.47% EBITDA 1,309.26 1,481.23 890.47 678.27 441.98 415.42 273.69 514.07 711.98 537.60 427.49 EBITDA Margin 22.46% 27.46% 19.28% 18.11% 13.57% 13.16% 9.55% 16.35% 21.69% 19.16% 18.15% Other Income 66.57 129.19 86.50 74.66 58.08 54.76 40.77 58.69 51.97 39.88 48.34 Interest 7.69 12.27 19.77 22.24 27.57 26.91 34.56 32.13 30.23 36.48 44.39 Depreciation 232.42 209.17 210.50 182.42 177.73 172.95 163.26 179.55 103.13 86.73 67.13 PBT 1,135.72 1,388.98 746.70 548.27 294.76 270.32 116.64 361.08 630.59 454.27 364.31 Tax 224.77 240.14 135.33 104.24 51.11 67.52 20.44 101.93 152.39 129.94 88.11 Tax Rate 19.79% 17.29% 18.12% 19.01% 17.34% 24.98% 17.52% 28.23% 24.17% 28.60% 24.19% PAT 910.95 1,147.71 614.13 447.39 243.65 202.80 96.20 259.15 478.20 324.33 276.20 PAT before Minority Interest 905.24 1,148.84 611.37 444.03 243.65 202.80 96.20 259.15 478.20 324.33 276.20 Minority Interest -5.71 -1.13 2.76 3.36 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 15.63% 21.27% 13.30% 11.94% 7.48% 6.43% 3.36% 8.24% 14.57% 11.56% 11.72% PAT Growth -20.71% 86.88% 37.27% 83.62% 20.14% 110.81% -62.88% -45.81% 47.44% 17.43% EPS 35.91 45.24 24.21 17.63 9.60 7.99 3.79 10.21 18.85 12.78 10.89

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Shareholder's Funds 4,752.72 3,677.54 3,136.66 2,694.94 2,475.12 2,283.05 2,233.33 1,981.61 1,569.85 1,262.27 Share Capital 25.37 25.27 25.27 25.24 25.24 25.24 25.24 25.24 25.24 25.17 Total Reserves 4,727.35 3,640.33 3,111.39 2,669.38 2,449.88 2,257.81 2,208.09 1,956.37 1,544.61 1,236.96 Non-Current Liabilities 191.82 265.43 307.04 420.11 546.49 661.70 696.75 456.21 509.21 432.58 Secured Loans 9.13 64.21 133.94 234.01 347.22 433.63 447.65 292.12 366.21 330.18 Unsecured Loans 0.00 14.17 0.00 0.00 4.52 50.65 53.75 0.00 0.00 0.00 Long Term Provisions 37.29 30.98 25.28 25.88 24.55 20.22 17.91 14.49 12.21 8.72 Current Liabilities 1,065.57 1,241.60 1,013.84 992.65 946.34 959.88 894.16 779.55 629.69 635.20 Trade Payables 609.76 537.85 464.09 414.75 388.06 415.24 302.56 337.05 265.46 230.71 Other Current Liabilities 195.21 294.88 266.94 262.00 315.35 296.09 234.93 249.82 165.18 174.56 Short Term Borrowings 147.45 309.27 195.86 239.04 177.30 182.86 320.98 137.96 157.14 201.36 Short Term Provisions 113.15 99.60 86.95 76.86 65.63 65.69 35.69 54.72 41.91 28.57 Total Liabilities 6,010.11 5,184.57 4,457.54 4,107.70 3,967.95 3,904.63 3,824.24 3,217.37 2,708.75 2,330.05 Net Block 1,868.60 1,840.97 1,740.10 1,854.61 1,945.97 1,976.58 1,752.96 1,306.11 1,075.33 912.82 Gross Block 2,883.37 2,679.08 2,412.97 2,358.72 2,276.99 2,137.32 2,465.90 1,851.29 1,524.85 1,284.51 Accumulated Depreciation 1,014.77 838.11 672.87 504.11 331.02 160.74 712.94 545.18 449.52 371.69 Non Current Assets 2,732.34 2,472.46 2,171.99 2,200.54 2,256.30 2,304.86 2,230.93 1,634.73 1,323.95 1,133.47 Capital Work in Progress 182.00 84.19 65.96 73.23 94.87 128.93 266.95 164.90 129.17 94.51 Non Current Investment 474.01 410.47 231.86 146.28 98.01 97.43 81.86 28.75 21.79 42.65 Long Term Loans & Adv. 182.34 123.30 128.11 115.80 103.53 79.61 118.33 125.12 87.77 76.13 Other Non Current Assets 25.39 13.53 5.96 10.62 13.92 22.31 10.83 9.85 9.89 7.36 Current Assets 3,277.77 2,712.11 2,285.55 1,907.16 1,711.65 1,599.77 1,593.31 1,582.64 1,384.80 1,196.58 Current Investments 393.83 238.25 90.38 69.35 113.57 0.00 0.00 0.15 0.15 0.15 Inventories 1,517.09 1,266.96 1,055.55 873.17 873.54 831.93 916.98 838.30 733.34 663.98 Sundry Debtors 774.46 839.13 632.06 594.38 501.98 441.45 353.55 448.76 415.93 340.91 Cash & Bank 306.90 152.40 259.81 131.03 17.53 161.98 113.19 69.22 54.66 9.25 Other Current Assets 285.49 192.85 218.35 225.55 205.03 164.41 209.59 226.21 180.72 182.29 Short Term Loans & Adv. 51.26 22.52 29.40 13.68 15.60 19.72 37.03 53.58 40.26 27.41 Net Current Assets 2,212.20 1,470.51 1,271.71 914.51 765.31 639.89 699.15 803.09 755.11 561.38 Total Assets 6,010.11 5,184.57 4,457.54 4,107.70 3,967.95 3,904.63 3,824.24 3,217.37 2,708.75 2,330.05

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Shareholder's Funds 4,701.65 3,627.48 3,122.39 2,688.57 2,455.26 2,259.19 2,208.43 1,959.66 1,553.78 1,254.01 Share Capital 25.37 25.27 25.27 25.24 25.24 25.24 25.24 25.24 25.24 25.17 Total Reserves 4,676.28 3,590.27 3,097.12 2,663.01 2,430.02 2,233.95 2,183.19 1,934.42 1,528.54 1,228.70 Non-Current Liabilities 217.10 290.29 313.40 419.42 548.32 662.57 699.57 459.45 509.52 433.15 Secured Loans 36.54 88.80 133.94 234.01 347.22 433.63 447.65 292.12 366.21 330.18 Unsecured Loans 0.00 14.17 6.91 0.00 4.52 50.64 55.56 1.88 0.00 0.00 Long Term Provisions 38.56 32.23 25.28 25.88 24.55 20.22 18.03 14.93 12.21 8.72 Current Liabilities 1,133.13 1,326.42 1,097.50 1,007.57 955.93 969.95 904.36 791.45 633.65 640.17 Trade Payables 666.17 609.85 524.32 423.47 396.54 421.11 306.59 340.99 268.37 234.52 Other Current Liabilities 203.12 304.57 274.74 266.75 316.41 297.50 236.44 250.88 166.00 175.33 Short Term Borrowings 149.20 310.95 209.69 239.04 177.30 184.85 325.35 143.94 157.14 201.36 Short Term Provisions 114.64 101.05 88.75 78.31 65.68 66.49 35.98 55.64 42.14 28.96 Total Liabilities 6,066.41 5,257.82 4,548.83 4,115.56 3,959.51 3,891.71 3,812.36 3,210.56 2,696.95 2,327.33 Net Block 2,072.43 2,058.73 1,940.38 1,952.96 1,983.27 2,014.18 1,800.43 1,353.59 1,104.23 944.08 Gross Block 3,185.55 2,985.73 2,632.86 2,464.33 2,318.22 2,176.95 2,546.33 1,932.05 1,579.07 1,338.55 Accumulated Depreciation 1,113.12 927.00 692.48 511.37 334.95 162.77 745.90 578.46 474.84 394.47 Non Current Assets 2,629.45 2,402.11 2,171.08 2,170.08 2,217.69 2,269.79 2,198.38 1,609.14 1,299.78 1,117.30 Capital Work in Progress 234.82 133.28 66.33 73.00 94.64 128.74 267.22 164.90 129.17 94.51 Non Current Investment 111.43 71.31 30.05 17.52 22.24 25.82 16.19 9.00 8.87 33.93 Long Term Loans & Adv. 184.42 124.68 128.36 115.83 103.58 78.44 103.47 71.26 47.49 37.12 Other Non Current Assets 26.35 14.11 5.96 10.77 13.96 22.61 11.07 10.39 10.02 7.66 Current Assets 3,436.96 2,855.71 2,377.75 1,945.48 1,741.82 1,621.92 1,613.98 1,601.42 1,397.17 1,210.03 Current Investments 393.83 238.25 90.38 69.35 113.57 0.00 0.00 0.15 0.15 0.15 Inventories 1,594.81 1,323.12 1,072.50 880.59 882.22 837.42 926.56 847.58 741.03 669.89 Sundry Debtors 811.75 895.20 681.51 602.27 500.16 445.87 353.00 449.79 417.81 344.88 Cash & Bank 365.07 180.92 282.30 150.57 35.85 175.54 124.79 76.01 58.24 12.16 Other Current Assets 271.50 195.92 221.21 228.26 210.02 163.09 209.63 227.89 179.94 182.95 Short Term Loans & Adv. 32.86 22.30 29.85 14.44 15.56 17.31 36.19 53.84 31.22 27.73 Net Current Assets 2,303.83 1,529.29 1,280.25 937.91 785.89 651.97 709.62 809.97 763.52 569.86 Total Assets 6,066.41 5,257.82 4,548.83 4,115.56 3,959.51 3,891.71 3,812.36 3,210.56 2,696.95 2,327.33

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Cash From Operating Activity 1,096.06 561.43 495.65 323.86 271.14 696.00 455.34 514.78 386.85 318.84 PBT 1,379.96 784.97 557.39 282.80 258.20 111.45 357.73 629.09 461.37 368.94 Adjustment 172.50 180.77 174.79 185.03 161.82 201.27 182.03 134.36 117.23 152.12 Changes in Working Capital -214.53 -257.90 -128.87 -86.56 -94.56 412.34 -9.96 -118.48 -100.02 -122.32 Cash after chg. in Working capital 1,337.93 707.84 603.31 381.27 325.46 725.06 529.80 644.97 478.58 398.74 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -241.87 -146.41 -107.66 -57.41 -54.32 -29.06 -74.46 -130.19 -91.73 -79.90 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -559.56 -499.13 -122.98 -119.34 -145.55 -213.62 -685.71 -362.07 -260.92 -251.45 Net Fixed Assets -302.10 -284.34 -46.98 -60.09 -105.61 466.60 -716.66 -362.17 -275.00 -298.69 Net Investments -219.12 -326.48 -106.61 -4.05 -114.15 -15.57 -52.96 -6.96 20.86 6.14 Others -38.34 111.69 30.61 -55.20 74.21 -664.65 83.91 7.06 -6.78 41.10 Cash from Financing Activity -307.38 -138.67 -222.83 -130.43 -156.39 -414.16 254.99 -138.36 -80.63 -69.02 Net Cash Inflow / Outflow 229.12 -76.37 149.84 74.09 -30.80 68.22 24.62 14.35 45.30 -1.63 Opening Cash & Equivalents 272.07 348.44 198.60 124.51 155.31 87.09 67.46 53.11 7.81 7.22 Closing Cash & Equivalent 501.19 272.07 348.44 198.60 124.51 155.31 92.08 67.46 53.11 7.81

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Cash From Operating Activity 1,090.13 570.35 501.03 341.13 281.91 708.65 455.29 522.29 388.77 353.84 PBT 1,381.28 738.89 546.46 290.53 262.06 116.64 361.08 630.59 454.27 364.31 Adjustment 190.77 247.37 187.36 192.51 174.86 211.11 187.91 139.92 126.16 156.99 Changes in Working Capital -236.33 -263.69 -121.97 -84.44 -103.73 410.30 -18.68 -117.72 -100.10 -87.39 Cash after chg. in Working capital 1,335.72 722.57 611.85 398.60 333.19 738.05 530.31 652.79 480.33 433.91 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -245.59 -152.22 -110.82 -57.47 -51.28 -29.40 -75.02 -130.50 -91.56 -80.07 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -520.69 -509.65 -165.06 -135.40 -148.82 -218.33 -676.40 -369.01 -259.87 -285.90 Net Fixed Assets -302.10 -284.34 -46.98 -60.09 -105.61 466.60 -716.66 -362.17 -275.00 -298.69 Net Investments -219.12 -326.48 -106.61 -4.05 -114.15 -15.57 -52.96 -6.96 20.86 6.14 Others 0.53 101.17 -11.47 -71.26 70.94 -669.36 93.22 0.12 -5.73 6.65 Cash from Financing Activity -305.82 -136.54 -183.20 -130.41 -159.13 -461.51 250.54 -136.13 -82.93 -71.81 Net Cash Inflow / Outflow 263.62 -75.84 152.77 75.32 -26.04 28.81 29.43 17.15 45.97 -3.87 Opening Cash & Equivalents 295.39 370.92 218.15 142.83 168.87 140.06 74.25 56.69 10.72 9.14 Closing Cash & Equivalent 559.01 295.39 370.92 218.15 142.83 168.87 103.68 74.25 56.69 10.72

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Book Value (Rs.) 187.34 290.11 248.25 213.52 196.13 180.91 176.97 157.02 124.39 100.29 ROA 20.38% 13.53% 10.62% 5.77% 4.78% 2.39% 7.27% 16.11% 13.15% 13.21% ROE 27.10% 19.18% 15.60% 9.02% 7.91% 4.10% 12.15% 26.88% 23.40% 24.20% ROCE 30.54% 20.84% 16.76% 9.53% 8.97% 4.52% 13.48% 27.57% 24.46% 23.86% Fixed Asset Turnover 1.85 1.72 1.52 1.39 1.43 1.24 1.45 1.94 2.00 2.07 Receivable days 57.30 61.48 61.61 62.15 54.52 51.03 46.94 48.31 49.28 55.23 Inventory Days 98.87 97.05 96.88 99.02 98.55 112.26 102.68 87.80 90.97 87.53 Payable days 134.01 47.09 49.40 50.05 51.96 52.98 39.18 36.44 31.15 30.32 Cash Conversion Cycle 22.16 111.44 109.09 111.12 101.10 110.31 110.44 99.66 109.10 112.44 Total Debt/Equity 0.05 0.12 0.14 0.23 0.29 0.38 0.42 0.30 0.39 0.48 Interest Cover 124.99 42.67 27.43 11.30 10.93 4.58 13.29 23.79 14.57 9.74

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Book Value (Rs.) 185.32 286.15 247.12 213.02 194.55 179.02 174.99 155.28 123.12 99.63 ROA 20.29% 12.47% 10.25% 6.03% 5.17% 2.50% 7.38% 16.19% 12.91% 13.03% ROE 27.63% 18.15% 15.28% 9.47% 8.60% 4.31% 12.43% 27.22% 23.10% 23.97% ROCE 30.92% 19.92% 16.53% 9.94% 9.44% 4.82% 13.78% 27.92% 24.38% 23.78% Fixed Asset Turnover 1.76 1.65 1.48 1.37 1.43 1.23 1.42 1.89 1.95 2.04 Receivable days 57.48 61.90 62.09 61.27 53.75 50.16 46.12 47.78 49.05 54.65 Inventory Days 98.25 94.05 94.47 97.98 97.70 110.76 101.93 87.49 90.74 87.21 Payable days 136.54 49.85 51.13 50.35 52.23 52.92 39.11 36.45 31.30 30.47 Cash Conversion Cycle 19.18 106.10 105.43 108.90 99.22 108.00 108.95 98.82 108.49 111.38 Total Debt/Equity 0.05 0.13 0.15 0.23 0.29 0.38 0.42 0.31 0.40 0.48 Interest Cover 114.20 38.77 25.65 11.69 11.05 4.38 12.24 21.86 13.45 9.21

Top Investors:

dsp midcap fund

hdfc trustee company ltd - a/c hdfc mid - capopportunities fund

icici prudential pharma healthcare and diaganostics (p.h.d) fund

mirae asset emerging bluechip fund

hdfc life insurance company limited

nippon life india trustee ltd-a/c nippon india growth fund

uti flexi cap fund

kotak emerging equity scheme

l and t mutual fund trustee ltd-l and t mid cap fund

axis mutual fund trustee limited a/c axis mutual fund a/c axis midcap fund

Annual Reports:

News Update:

Ipca Laboratories - Quarterly Results
24th May 2022, 13:11 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback